| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 31st December 2020 | Tim B Johnson | 109 | Payment by withholding | $4.79 | $522.11 |
| 31st December 2020 | John L Lubniewski | 62 | Payment by withholding | $4.79 | $296.98 |
| 31st December 2020 | Byron Lawson | 24 | Payment by withholding | $4.79 | $114.96 |
| 31st December 2020 | Shaun D Mc Means | 31 | Payment by withholding | $4.79 | $148.49 |
| 21st December 2020 | Ann Hanham | 3,200 | Open or private purchase | $6.25 | $20,000.00 |
| 14th December 2020 | Michelle Renee Griffin | 982 | Open or private sale | $57.42 | $56,386.44 |
| 14th December 2020 | Michelle Renee Griffin | 1,651 | Open or private sale | $59.44 | $98,135.44 |
| 14th December 2020 | Michelle Renee Griffin | 3,367 | Open or private sale | $58.96 | $198,518.32 |
| 14th December 2020 | Michelle Renee Griffin | 6,000 | Exercise of derivative | $7.80 | $46,800.00 |
| 10th December 2020 | Tim B Johnson | 34 | Grant/award etc. | $4.87 | $165.60 |
Htg Molecular Diagnostics
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
HTG Molecular Diagnostics, Inc. provides molecular technology solutions that facilitates molecular profiling. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.
Ticker: HTGM
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 1169987
Employees: 107
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
HTG Announces Board of Directors Transition
19th January 2021
